Reichman B S
Cornell University Medical College, USA.
Oncology (Williston Park). 1997 Feb;11(2 Suppl 1):55-8.
Tamoxifen citrate has been prescribed to millions of women with breast cancer and has been one of the most important advances in breast cancer treatment over the past 25 years. Because she is a female physician, the author's patients tend to be particularly open about their concerns regarding breast cancer and its treatment. Women accept tamoxifen as a treatment because of its demonstrated efficacy in breast cancer, extending survival and reducing contralateral breast cancer. They also recognize the potential benefits of secondary effects on lipids and bone. However, patients do have concerns regarding side effects and their impact on everyday life.
数百万乳腺癌女性患者都曾服用过枸橼酸他莫昔芬,在过去25年里,该药一直是乳腺癌治疗领域最重要的进展之一。由于作者是一名女医生,她的患者往往对自己有关乳腺癌及其治疗的担忧特别坦诚。女性接受他莫昔芬作为一种治疗手段,是因为其在乳腺癌治疗中已证实的疗效,可延长生存期并降低对侧乳腺癌的发病率。她们也认识到该药对脂质和骨骼的继发性影响可能带来的益处。然而,患者确实担心副作用及其对日常生活的影响。